Sinopharm Tech Holdings (HKSE:08156) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08156 Sinopharm Tech Holdings Ltd HKSE:08156
27 GF Score
Price HK$0.16
GF Value HK$0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sinopharm Tech Holdings FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:08156
27GF Score
Sinopharm Tech Holdings Ltd HKSE:08156
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued. The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06. GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:08156:

  • FFO:
  • GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinopharm Tech Holdings Business Description

Address Ruttonjee Centre, 11 Duddell Street Central, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score

Get the complete analysis for HKSE:08156

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.06
GF Value